Toggle Site Contrast Toggle Site Contrast

2022 Medicine Disclosure Logs

Ovarian Cancer Patients Treatment – FOI 1057,

Dermatology Patients Treatment – FOI 1058,

Dermatology and Rheumatology Patients Treatment November 2021 – FOI 1068,

Shigellosis – FOI 1089,

Rheumatology Patients Treated With Drugs – FOI 1110,

Dermatology Patients Treated with Drugs – FOI 1121,

Drugs Treatment in the Last 6 Months – FOI 1126,

Ventilated Beds Dec 2021 FOI 1078,

Critical Care Beds Information - FOI 1372,

Drugs used for patient treatments - FOI 1062,

Drugs used to treat Melanoma, Renal carcinoma & Oesophageal cancer - FOI 1297,

Patients registered for Haemophilia treatment- FOI 1301,

Treatment of patients with Chronic Lymphocytic Leukaemia March to April 2022 - FOI 1341,

Collection of performance data for the CCG2 CQUIN scheme “Appropriate antibiotic prescribing for UTI in adults aged 16+” between 1st April 2022 and the 1st April 2023 - FOI 1356,

Number of patients who died whilst awaiting discharge - FOI 1379,

Drug treatments for Melanoma, Renal Cell Carcinoma and GI Cancer May to July 2022 - FOI 1539,

Anti-VEGF Treatment January 2022 - April 2022 - FOI 1383,

Drug Treatments used April to June 2022 - FOI 1492,

Dabrafenib + Trametinib for cancer treatments Jan to June 2022 - FOI 1468,

Usages of medicines in secondary care Oct 2021 to March 2022 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 1 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 2 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 3 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 4 - FOI 1353,

Do not resuscitate policy June 2022 - FOI 1502,

Do not resuscitate policy attachment 1 - FOI 1502,

Portable Bilirubin Meter Information - FOI 1497,

Treatment of Patients with Melanoma - FOI 1279,

Drugs used in Treatments Dec 2021 to May 2022 - FOI 1364,

Usage of Intra-Vitreal Injections Jan to April 2022 - FOI 1365,

Drugs used for Dermatology and Gastro patients March to May 2022 - FOI 1366,